Advertisement
Skip to Content

Eli Lilly and Co LLY Stock Quote

| Rating as of

NYSE: LLY

Last close prices updated as of Feb 07, 2023, 7:00 PM EST | USD | BATS BZX Real-Time Price
  • Last Close 339.68
  • Sector Healthcare
  • Industry Drug Manufacturers - General
  • Investment Style Large Growth
  • Day Range 332.69  –  340.96
  • Year Range 231.87  –  384.44
  • Market Cap 322.7564 Bil
  • Volume / Avg 2.5 Mil /  2.7 Mil
  • Price / Sales 11.31
  • Price / Book 32.05
  • Forward Div Yield 1.33%
  • Trailing Div Yield 1.49%

Morningstar‘s Stock Analysis LLY

Valuation
Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price

INVESTOR

5-Star Price

INVESTOR

Economic Moat

INVESTOR

Capital Allocation

INVESTOR

Lilly Posts Solid Q4 Relative to Our Projections but Likely Below the High Market Expectations

Damien Conover Sector Director

Analyst Note

| Damien Conover |

Eli Lilly reported fourth-quarter results slightly ahead of our expectations, and we plan to increase our fair value estimate. However, the market is negatively reacting to the results, which we believe is due to performance of diabetes drug Mounjaro. The drug saw $297 million in sales, which is a strong number for a new drug but likely below what many were expecting, given the very strong prescriptions trends. We believe the low insurance coverage rate (now close to 50% in the U.S.) for the drug is weighing down sales relative to the prescription trends. We expect Mounjaro coverage to continue to improve and sales to rapidly increase.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics LLY

Company Profile LLY

Business Description

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Contact
Lilly Corporate Center
Indianapolis, IN, 46285
Industry Drug Manufacturers - General
Employees 35,000

Related Articles LLY

FAQs for Eli Lilly and Co Stock

Yes. LLY has a forward dividend yield of 1.34%. See LLY’s full dividends and stock split history on the Dividend tab.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

LLY’s market cap is 322.76 Bil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

LLY’s stock style is Large Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

LLY’s price/sales is 11.24.
Price/sales represents the amount an investor is willing to pay for a dollar generated from a particular company’s sales or revenues.

LLY’s price/forward earnings is 39.06.
Forward P/E gives some indication of how cheap or expensive a stock is compared with consensus earnings estimates. The lower the Forward P/E, the cheaper the stock.

LLY’s price/book is 32.05.
Price/book ratio can tell investors approximately how much they’re paying for a company’s assets, based on historical, rather than current, valuations. Historical valuations generally do not reflect a company’s current market value. Value investors frequently look for companies that have low price/book ratios.

See LLY’s valuation ratios compared to the Market Index.

LLY’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare LLY’s historical performance against its industry peers and the overall market.